Nektar Therapeutics
NKTR· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2014 | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|---|
| Revenue | $19.77M | $23.00M | $17.95M | $11.30M |
| Net Income | -$46.20M | -$55.06M | -$41.10M | -$36.03M |
| EPS Diluted | -$0.37 |
Nektar Therapeutics · CIK 906709 · Engraved from SEC EDGAR
| -$0.48 |
| -$0.36 |
| -$0.33 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.